Shares of Global Blue Group Holding AG GB rose sharply during Wednesday's pre-market trading session after the company announced it will be acquired by Shift4 for $7.50 per share.
Global Blue Group shares jumped 18.3% to $7.37 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Cycurion, Inc. CYCU rose 132.5% to $7.79 in pre-market trading after dipping 72% on Tuesday.
- OSR Holdings, Inc. OSRH shares jumped 96.4% to $6.11 in pre-market trading after gaining 3% on Tuesday.
- Lytus Technologies Holdings PTV. Ltd. LYT gained 52.7% to $0.34 in pre-market trading after dipping 14% on Tuesday.
- ReShape Lifesciences Inc. RSLS gained 43.3% to $1.55 in pre-market trading. ReShape Lifesciences shares dipped around 54% on Tuesday after the company announced a $6 million public offering of 2,575,107 units at $2.33 per unit.
- Sintx Technologies, Inc. SINT shares climbed 38.3% to $3.90 in pre-market trading. Sintx Technologies announced the issuance of U.S. patent no. 12,239,761 by the United States Patent and Trademark Office.
- NewGenIvf Group Limited NIVF gained 35.2% to $2.96 in pre-market trading after gaining around 12% on Tuesday.
- TruGolf Holdings, Inc. TRUG gained 33.1% to $0.5444 in pre-market trading after the company guided 2024 sales of $22.5 million and 2H adjusted EBITDA above $2.2 million.
- Aditxt, Inc. ADTX gained 22.3% to $0.1345 in pre-market after surging 57% on Tuesday.
- Mercurity Fintech Holding Inc. MFH rose 14.5% to $8.00. MFH’s majority-owned subsidiary Aifinity Base Limited plans to manufacture advanced liquid cooling solutions for Nvidia® chip-powered AI data centers and high-performance computing.
Losers
- Movano Inc. MOVE shares fell 36.4% to $3.25 in pre-market trading.
- Aptose Biosciences Inc. APTO shares fell 25.5% to $0.1439 in pre-market trading after gaining around 8% on Tuesday.
- Design Therapeutics, Inc DSGN dipped 24.5% to $3.120 in pre-market trading.
- Supernus Pharmaceuticals, Inc. SUPN fell 22% to $31.00 in pre-market trading after the company announced that the Phase 2b study of SPN-820 in adults with treatment-resistant depression did not demonstrate a statistically significant improvement on the primary endpoint of change from baseline in the Montgomery-Åsberg Depression Rating Scale.
- InnovAge Holding Corp. INNV fell 21.1% to $2.70 in today's pre-market trading. InnovAge recently reported worse-than-expected second-quarter financial results.
- MGO Global, Inc. MGOL shares tumbled 20.9% to $0.3680 in pre-market trading after dipping 35% on Tuesday. MGO Global’s stockholders approved business combination with Heidmar.
- Bumble Inc. BMBL declined 17.3% to $6.70 in pre-market trading after the company issued first-quarter revenue guidance below estimates and announced a quarter-over-quarter decline in paying app users.
- Gentherm Incorporated THRM fell 17% to $30.00 in pre-market trading following weak quarterly results.
- Celanese Corporation CE shares dipped 13.5% to $60.50 in pre-market trading after the company issued first-quarter EPS guidance below estimates.
- Nexa Resources S.A. NEXA fell 10.6% to $4.60 in pre-market trading following a 7% decline on Tuesday.
Now Read This:
APTOAptose Biosciences Inc
$0.1450-3.27%
BMBLBumble Inc
$5.700.97%
CECelanese Corp
$54.70-0.38%
CYCUCycurion Inc
$2.68-9.76%
DSGNDesign Therapeutics Inc
$4.87-%
GBGlobal Blue Group Holding AG
$7.27-0.68%
INNVInnovAge Holding Corp
$3.35-%
LYTLytus Technologies Holdings Pvt Ltd
$0.2930-18.6%
MFHMercurity Fintech Holding Inc
$6.96-6.33%
MGOLMGO Global Inc
$0.3058-17.4%
MOVEMovano Inc
$4.00-21.9%
NEXANexa Resources SA
$5.11-4.84%
NIVFNewGenIvf Group Ltd
$2.416.17%
OSRHOSR Holdings Inc
$4.30-21.3%
RSLSReshape Lifesciences Inc
$1.24-8.82%
SINTSINTX Technologies Inc
$4.45-7.68%
SUPNSupernus Pharmaceuticals Inc
$34.332.42%
THRMGentherm Inc
$33.35-%
TRUGTruGolf Holdings Inc
$0.4575-10.9%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in